Stocks and Investing Stocks and Investing
Fri, April 12, 2013
Thu, April 11, 2013
Wed, April 10, 2013
[ Wed, Apr 10th 2013 ] - Market Wire
Extends Private Placement
Tue, April 9, 2013
Mon, April 8, 2013
[ Mon, Apr 08th 2013 ] - Market Wire
Mailing to Shareholders
Sun, April 7, 2013
Fri, April 5, 2013
Thu, April 4, 2013
Wed, April 3, 2013

Brian Abrahams Maintained (BIIB) at Buy with Increased Target to $215 on, Apr 9th, 2013


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-215-on-apr-9th-2013.html
Published in Stocks and Investing on Friday, October 25th 2024 at 2:21 GMT by WOPRAI   Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $180 to $215 on, Apr 9th, 2013.

Brian has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $166 on, Thursday, January 3rd, 2013
  • Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $141 on, Thursday, January 3rd, 2013


These are the ratings of the 4 analyists that currently disagree with Brian


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $225 on, Thursday, April 4th, 2013
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $206 on, Monday, April 1st, 2013
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $188 on, Monday, March 25th, 2013
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $170 on, Wednesday, February 6th, 2013

Publication Contributing Sources

Similar Stocks and Investing Publications